I
3.28
0.73 (28.63%)
| Penutupan Terdahulu | 2.55 |
| Buka | 2.50 |
| Jumlah Dagangan | 1,181,608 |
| Purata Dagangan (3B) | 92,238 |
| Modal Pasaran | 105,510,968 |
| Harga / Jualan (P/S) | 17.44 |
| Harga / Buku (P/B) | 196.27 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 11 May 2026 |
| Margin Operasi (TTM) | -273.01% |
| EPS Cair (TTM) | -3.79 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 1,114.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 34.04% |
| Nisbah Semasa (MRQ) | 3.74 |
| Aliran Tunai Operasi (OCF TTM) | -22.74 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -15.27 M |
| Pulangan Atas Aset (ROA TTM) | -22.17% |
| Pulangan Atas Ekuiti (ROE TTM) | -428.96% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | Insight Molecular Diagnostics I | Menaik | - |
AISkor Stockmoo
0.4
| Konsensus Penganalisis | 3.5 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.40 |
|
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company’s flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 22.47% |
| % Dimiliki oleh Institusi | 56.26% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Broadwood Capital Inc | 31 Dec 2025 | 11,410,100 |
| Julat 52 Minggu | ||
| Median | 12.00 (265.85%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Lake Street | 17 Feb 2026 | 12.00 (265.85%) | Beli | 5.39 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| JAMES ANDREA S. | - | 4.11 | -11,298 | -46,435 |
| LIU JAMES YANG | - | 4.11 | -2,578 | -10,596 |
| RIGGS JOSH | - | 4.11 | -12,310 | -50,594 |
| Jumlah Keseluruhan Kuantiti Bersih | -26,186 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -107,624 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 4.11 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| LIU JAMES YANG | Pegawai | 26 Mar 2026 | Dibuang (-) | 2,578 | 4.11 | 10,596 |
| LIU JAMES YANG | Pegawai | 26 Mar 2026 | Pelaksanaan pilihan | 6,289 | - | - |
| RIGGS JOSH | Pegawai | 26 Mar 2026 | Dibuang (-) | 12,310 | 4.11 | 50,594 |
| RIGGS JOSH | Pegawai | 26 Mar 2026 | Pelaksanaan pilihan | 47,170 | - | - |
| JAMES ANDREA S. | Pegawai | 26 Mar 2026 | Dibuang (-) | 11,298 | 4.11 | 46,435 |
| JAMES ANDREA S. | Pegawai | 26 Mar 2026 | Pelaksanaan pilihan | 28,302 | - | - |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 13 Jan 2026 | Pengumuman | IMDX Supports AST and ASHI STAR Working Group’s Call for Decentralized Transplant Monitoring |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |